At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
Lotrafilcon B contact lens +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Subjective Evaluation of a Commercially Marketed Contact Lens Amongst a Subset of the Contact Lens Wearing Population
In Brief
A clinical study evaluating Lotrafilcon B contact lens and Habitual contact lens for Myopia. Completed, enrolled 50 participants.
Detailed Summary
The purpose of this study is to compare the performance of commercially marketed contact lenses to habitual contact lenses in a selected segment of the contact lens wearing population.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2009
First PostedNov 2009
Primary CompletionJan 2010
TodayJul 2026
First PostedNov 5, 2009
Enrollment StartOct 1, 2009
Primary CompletionJan 1, 2010
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 16.7 years ago
Interventions
Lotrafilcon B contact lensdevice
Commercially marketed, silicone hydrogel, spherical contact lens having a recommended replacement schedule of monthly.
Habitual contact lensdevice
Habitual soft spherical contact lens having a recommended replacement schedule of 2 weeks or monthly.